We are live on ! Find out more
JLBC

J.L. Bainbridge & Co Portfolio holdings

AUM $1.27B
1-Year Est. Return 26.55%
This Fund
S&P 500
This Quarter Est. Return
+11.38%
1 Year Est. Return
+26.55%
3 Year Est. Return
+93.81%
5 Year Est. Return
+120.16%
10 Year Est. Return
–
AUM
$719M
AUM Growth
+$50.1M
Cap. Flow
-$16.1M
Cap. Flow %
-2.23%
Top 10 Hldgs %
74.32%
Holding
96
New
17
Increased
25
Reduced
29
Closed
11

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$34.5M
2
CVS icon
CVS Health
CVS
+$31.7M
3
RTN
Raytheon Company
RTN
+$18.9M
4
REM icon
iShares Mortgage Real Estate ETF
REM
+$401K
5
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$400K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$40.6M
2
WGO icon
Winnebago Industries
WGO
+$25.2M
3
BLK icon
Blackrock
BLK
+$18.2M
4
ILPT
Industrial Logistics Properties Trust
ILPT
+$6.94M
5
GILD icon
Gilead Sciences
GILD
+$2.56M

Sector Composition

Rank Sector Weight
1 Industrials 33.55%
2 Technology 24.48%
3 Communication Services 18.93%
4 Healthcare 12.59%
5 Consumer Discretionary 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PM icon
76
Philip Morris
PM
$299B
$222K 0.03%
+2,605
New +$215K
FNDA icon
77
Schwab Fundamental US Small Company Index ETF
FNDA
$9.15B
$219K 0.03%
+10,872
New +$211K
XYL icon
78
Xylem
XYL
$26B
$213K 0.03%
2,700
– –
HON icon
79
Honeywell
HON
$68.9B
$212K 0.03%
1,269
+1
+0.1% +$163
BABA icon
80
Alibaba
BABA
$296B
$203K 0.03%
+957
New +$180K
AMCR icon
81
Amcor
AMCR
$21.6B
$165K 0.02%
3,039
– –
GRCE
82
Grace Therapeutics
GRCE
$44.6M
$157K 0.02%
1,336
+417
+45% +$41.2K
ESBA icon
83
Empire State Realty Series ES
ESBA
$1.3B
$155K 0.02%
+11,131
New +$156K
ATRS
84
DELISTED
Antares Pharma, Inc.
ATRS
$141K 0.02%
30,000
– –
JFR icon
85
Nuveen Floating Rate Income Fund
JFR
$1.23B
$113K 0.02%
+11,044
New +$106K
ACB
86
Aurora Cannabis
ACB
$254M
– –
-120
Closed -$63K
IBM icon
87
IBM
IBM
$222B
– –
-1,507
Closed -$210K
IJK icon
88
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
– –
-8,068
Closed -$390K
ILPT
89
Industrial Logistics Properties Trust
ILPT
$557M
– –
-326,411
Closed -$6.94M
RY icon
90
Royal Bank of Canada
RY
$283B
– –
-2,500
Closed -$203K
SLV icon
91
iShares Silver Trust
SLV
$32.3B
– –
-15,196
Closed -$242K
VEA icon
92
Vanguard FTSE Developed Markets ETF
VEA
$238B
– –
-8,800
Closed -$362K
VWO icon
93
Vanguard FTSE Emerging Markets ETF
VWO
$127B
– –
-5,132
Closed -$207K
PTLA
94
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-7,434
Closed -$199K
STI
95
DELISTED
SunTrust Banks, Inc.
STI
– –
-3,735
Closed -$257K
CELG
96
DELISTED
Celgene Corp
CELG
– –
-409,085
Closed -$40.6M
1 2 3
4

Similar funds

KA
KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return
BFS
Baskin Financial Services Toronto, Ontario, Canada $1.27B AUM 9.68% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
WA
Wealth Architects Mountain View, California $1.27B AUM 36.93% 1-Year Est. Return
CAM
Clark Asset Management Stratham, New Hampshire $1.27B AUM 17.17% 1-Year Est. Return
JTWM
Jackson Thornton Wealth Management Montgomery, Alabama $1.26B AUM 29.39% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.27B AUM 23.08% 1-Year Est. Return

J.L. Bainbridge & Co's Q4 2019 Portfolio in Review

As of Q4 2019, J.L. Bainbridge & Co held 96 positions worth $719M, up 7.5% from $669M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

J.L. Bainbridge & Co's Q4 2019 filing shows 17 new, 25 increased, 29 reduced and 11 closed positions. Its largest new stake was Bristol-Myers Squibb: 602,603 shares worth $38.7M. The largest sale was Celgene Corp, an estimated $40.6M.

By sector, the portfolio is most concentrated in Industrials at 34% of assets, up from 32% a quarter earlier, followed by Technology and Communication Services.

  • J.L. Bainbridge & Co's largest Q4 2019 buy was Bristol-Myers Squibb: 602,603 shares worth $38.7M.
  • J.L. Bainbridge & Co added most to iShares iBonds Dec 2022 Term Corporate ETF in Q4 2019, an estimated $387K increase.
  • J.L. Bainbridge & Co's biggest Q4 2019 reduction was Winnebago Industries, cutting an estimated $25.2M.
  • J.L. Bainbridge & Co fully exited Celgene Corp in Q4 2019, selling an estimated $40.6M.
  • J.L. Bainbridge & Co's ten largest holdings make up 74% of its $719M portfolio in Q4 2019.
  • J.L. Bainbridge & Co opened 17 new positions and closed 11 in Q4 2019.
  • J.L. Bainbridge & Co's portfolio value rose 7.5% quarter-over-quarter to $719M.

Based on J.L. Bainbridge & Co's 13F filing for Q4 2019, filed 13 Feb 2020.